Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial
Copyright policy )Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial
Fosmanogepix (FMGX), a novel antifungal available in intravenous (IV) and oral formulations, has broad-spectrum activity against pathogenic yeasts and molds, including fungi resistant to standard of care antifungals. This multicenter, open-label, single-arm study evaluated FMGX safety and efficacy for treatment of candidemia and/or invasive candidiasis caused by Candida auris .
- Steve Biko Hospital South Africa
- University of the Witwatersrand South Africa
- Pfizer (United States) United States
- Milpark Hospital South Africa
- Augusta University United States
Intensive care unit (ICU), SDG-17: Partnerships for the goals, Male, SDG-03: Good health and well-being, Antifungal Agents, APX001, Fosmanogepix (FMGX), 610, Microbial Sensitivity Tests, Health sciences articles SDG-17, Gwt1 inhibitor, 616, Humans, Experimental Therapeutics, Candidiasis, Invasive, Fosmanogepix, Health sciences articles SDG-03, Candidiasis, Candidemia, Candida auris, Treatment Outcome, Female, Isocyanates
Intensive care unit (ICU), SDG-17: Partnerships for the goals, Male, SDG-03: Good health and well-being, Antifungal Agents, APX001, Fosmanogepix (FMGX), 610, Microbial Sensitivity Tests, Health sciences articles SDG-17, Gwt1 inhibitor, 616, Humans, Experimental Therapeutics, Candidiasis, Invasive, Fosmanogepix, Health sciences articles SDG-03, Candidiasis, Candidemia, Candida auris, Treatment Outcome, Female, Isocyanates
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).57 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
Citations provided by BIP!Popularity provided by BIP!